Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $18,901 - $22,093
589 Added 10.58%
6,158 $204,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $8,018 - $9,277
-222 Reduced 3.83%
5,569 $204,000
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $21,940 - $28,562
557 Added 10.64%
5,791 $236,000
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $218,519 - $285,253
5,234 New
5,234 $268,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $8,235 - $9,765
-177 Reduced 4.36%
3,884 $204,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $1,967 - $2,437
43 Added 1.07%
4,061 $210,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $166,023 - $246,102
4,018 New
4,018 $237,000
Q2 2020

Aug 03, 2020

SELL
$30.12 - $36.54 $95,179 - $115,466
-3,160 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$27.03 - $38.62 $85,414 - $122,039
3,160 New
3,160 $103,000
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $104,027 - $118,057
-3,160 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $32,490 - $42,130
-1,000 Reduced 24.04%
3,160 $114,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $2,884 - $3,238
-78 Reduced 1.84%
4,160 $180,000
Q1 2019

Apr 15, 2019

SELL
$37.5 - $41.2 $16,125 - $17,716
-430 Reduced 9.21%
4,238 $180,000
Q4 2018

Jan 18, 2019

SELL
$38.47 - $43.86 $89,712 - $102,281
-2,332 Reduced 33.31%
4,668 $203,000
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $131,089 - $159,003
3,803 Added 118.96%
7,000 $0
Q2 2018

Aug 01, 2018

SELL
$32.98 - $35.16 $174,563 - $186,101
-5,293 Reduced 62.34%
3,197 $221,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $33,377 - $38,722
1,046 Added 14.05%
8,490 $301,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $230,764 - $254,212
7,444
7,444 $265,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Paragon Capital Management LLC Portfolio

Follow Paragon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LLC with notifications on news.